Latest Financial Guidance News

Vault Minerals projects steady gold production in FY26 with growth through FY28, driven by key plant upgrades and the anticipated restart of Sugar Zone operations. The company plans significant capital and exploration investments while preparing to fully unwind its hedge book.

Elanor Commercial Property Fund has reaffirmed its FY26 distribution guidance while urging securityholders to reject a takeover offer it deems undervalued and opportunistic.

Blue Star Helium Limited reports steady progress on its Galactica helium project in Colorado, with first helium production on track for December 2025 and full ramp-up expected through 2026.

Native Mineral Resources has significantly increased gold production at its Blackjack operations, producing 700 ounces of gold doré bars in its latest smelts, marking a clear step towards steady-state operations.

Gold Road Resources has lowered its 2025 gold production guidance and raised cost estimates following operational setbacks at the Gruyere joint venture mine.

Advanced Braking Technology has appointed CEO Andrew Booth to the Board as Managing Director, signaling confidence in his leadership amid ongoing growth.

Alkane Resources has unveiled its FY2026 production and cost guidance following its merger with Mandalay Resources, projecting significant growth across its Australian and Swedish operations.

RPMGlobal Holdings clarifies the reasons behind withdrawing its FY2025 earnings guidance following the divestment of its Advisory business, providing detailed updates on software segment performance and compliance with ASX disclosure rules.

Adrad Holdings announces immediate board reshuffle with Chairman Glenn Davis stepping down, CEO Paul Proctor promoted to Managing Director, and Donald McGurk appointed Chairman.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Amaero Ltd has updated its FY2026 financial guidance, forecasting revenue between A$30 million and A$35 million; a staggering 800%-900% increase year-over-year; and announced a A$50 million capital raise to expand production capacity and reduce costs.

Biome Australia Limited projects its Q1 FY26 sales revenue to exceed $5.5 million, breaking its previous quarterly record and signaling continued momentum in the microbiome health sector.